Evidence map›Paper›PMID 24666322›Full record

ArticleJournal of neurochemistry2014

HIV-1 protein Tat produces biphasic changes in NMDA-evoked increases in intracellular Ca2+ concentration via activation of Src kinase and nitric oxide signaling pathways.

Kelly A Krogh, Nicole Wydeven, Kevin Wickman, Stanley A Thayer

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Infectious Diseases.Advances in neurobiology · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Host-virus interaction and viral evasion.Cell biology international · 2021
    Review
  10. Article
  11. HIV and opiates dysregulate KNeurobiology of disease · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Scaling Synapses in the Presence of HIV.Neurochemical research · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kelly A KroghDepartment of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Nicole Wydeven
Kevin Wickman
Stanley A Thayer
University of Minnesota Medical Center · USUniversity of Minnesota · US

Funding

Training in PharmacoNeuroImmune Substance Abuse ResearchT32DA007097 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI MOLITOR, THOMAS WILLIAM · 1985 to 2021
$13.1M
NEUROSCIENCE TRAINING IN DRUG ABUSE RESEARCHT32DA007234 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Paul G Mermelstein, Jocelyn M Richard · 1986 to 2026
$10.9M
HIV NEUROTOXICITY--MECHANISM &MODULATION BY CANABINOIDSR01DA007304 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI THAYER, STANLEY A · 1992 to 2024
$5.0M
G protein-gated K+ channels and inhibitory signalingR01MH061933 · NIMH · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WICKMAN, KEVIN D · 2001 to 2016
$4.4M
Relevance and plasticity of inhibitory metabotropic signaling in reward circuitsR01DA034696 · NIDA · UNIVERSITY OF MINNESOTA · PI WICKMAN, KEVIN D · 2013 to 2022
$3.4M
HIV Neurotoxicity-Mechanism &Modulation by CannabinoidsR37DA007304 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI THAYER, STANLEY A · 2004 to 2013
$3.1M
RESEARCH TRAINING IN DRUG ABUSE BEHAVIORT32DA007304 · NIDA · UNIVERSITY OF KENTUCKY · PI RUSH, CRAIG R · 1998 to 2012
$3.1M
Pharmacological modulation of synapses and cognition during HIV-1 neurotoxicityR21DA035663 · NIDA · UNIVERSITY OF MINNESOTA · PI THAYER, STANLEY A · 2013 to 2014
$418k
NIDA NIH HHS DA007097NIDA NIH HHS DA007234NIDA NIH HHS DA034696NIDA NIH HHS DA035663NIDA NIH HHS DA07304NIDA NIH HHS R01 DA007304NIDA NIH HHS R01 DA034696NIDA NIH HHS R21 DA035663NIDA NIH HHS R37 DA007304NIDA NIH HHS T32 DA007097NIDA NIH HHS T32 DA007234NIDA NIH HHS T32 DA007304NIMH NIH HHS MH061933NIMH NIH HHS R01 MH061933
6 · The paper itself

Abstract

HIV-associated neurocognitive disorders afflict about half of HIV-infected patients. HIV-infected cells shed viral proteins, such as the transactivator of transcription (Tat), which can cause neurotoxicity by over activation of NMDA receptors. Here, we show that Tat causes a time-dependent, biphasic change in NMDA-evoked increases in intracellular Ca(2+) concentration ([Ca(2+)]i). NMDA-evoked responses were potentiated following 2-h exposure to Tat (50 ng/mL). Tat-induced potentiation of NMDA-evoked increases in [Ca(2+)]i peaked by 8 h and then adapted by gradually reversing to baseline by 24 h and eventually dropping below control by 48 h. Tat-induced potentiation of NMDA-evoked responses was blocked by inhibition of lipoprotein receptor-related protein (LRP) or Src tyrosine kinase. Potentiation was unaffected by inhibition of nitric oxide synthase (NOS). However, NOS activity was required for adaptation. Adaptation was also prevented by inhibition of soluble guanylate cyclase (sGC) and cyclic guanosine monophosphate-dependent protein kinase G (PKG). Together, these findings indicate that Tat potentiates NMDA-evoked increases in [Ca(2+)]i via LRP-dependent activation of Src and that this potentiation adapts via activation of the NOS/sGC/PKG pathway. Adaptation may protect neurons from excessive Ca(2+) influx and could reveal targets for the treatment of HIV-associated neurocognitive disorders. HIV-associated neurocognitive disorders (HAND) afflict about half of HIV-infected patients. HIV-infected cells shed viral proteins, such as the transactivator of transcription (Tat), which can cause neurotoxicity by over activation of NMDA receptors (NMDARs). We show that HIV-1 Tat evoked biphasic changes in NMDA-evoked [Ca(2+) ]i responses. Initially, Tat potentiated NMDA-evoked responses following LRP-mediated activation of Src kinase. Subsequently, Tat-induced NMDAR potentiation adapted by activation of a NOS/sGC/PKG pathway that attenuated NMDA-evoked increases in [Ca(2+)]i . Adaptation may be a novel neuroprotective mechanism to prevent excessive Ca(2+) influx. Solid and dashed arrows represent direct and potentially indirect connections, respectively.

Indexed as

AnimalsCalciumCells, CulturedHIV-1HIV InfectionsImmunoblottingNeuronsNitric OxideN-MethylaspartateRatsReceptors, N-Methyl-D-AspartateSignal Transductionsrc-Family Kinasestat Gene Products, Human Immunodeficiency VirusTransfectionCalciumNitric OxideN-MethylaspartateReceptors, N-Methyl-D-Aspartatesrc-Family Kinasestat Gene Products, Human Immunodeficiency VirusHIV-1 Tatintracellular calciumnitric oxdeNMDA receptorprotein kinase GSrc

Identifiers

PMID24666322
PMCPMC4141023
OpenAlexW2068321659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.